MDM2

Class

Small molecule MDM2-p53 protein-protein interaction inhibitor

Pathway

p53 tumor-suppressor pathway reactivation

MDM2 is a cellular protein that acts as the principal negative regulator of p53, a transcription factor often called a tumor suppressor because it triggers cell-cycle arrest, DNA repair programs, or programmed cell death (apoptosis) in response to cellular stress or DNA damage. Under normal conditions, MDM2 binds p53 and marks it for degradation, keeping p53 activity low so that cells can proliferate when appropriate. In many cancers, particularly those that retain a structurally normal (wild-type) p53 gene, tumor cells amplify or overexpress MDM2 to suppress p53 function, allowing damaged or malignant cells to survive and divide unchecked. Small molecules that block the physical interaction between MDM2 and p53 prevent this suppression, allowing p53 to accumulate and resume its normal tumor-suppressive signaling, which can push cancer cells toward growth arrest or apoptosis. This approach, known as p53 pathway reactivation, is distinct from cytotoxic chemotherapy because it relies on restoring an endogenous safeguard rather than directly damaging DNA. It is of broad interest across tumor types where p53 is intact but functionally silenced, including certain sarcomas, leukemias, and solid tumors with MDM2 amplification.